Author

Arnaud Bruneel

InsermORCID 0000-0001-8411-3309Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Ahmed IdbaïhiD· 1 shared Andrea Jáñez PedrayesiD· 1 shared Andreas De La Vara· 1 shared Ashwin NarayananiD· 1 shared Bart GhesquièreiD· 1 shared Chris OttolenghiiD· 1 shared Clément PontoizeauiD· 1 shared Cristina CheroniiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmed IdbaïhORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 29, 2026

COG5-mediated Golgi organization coordinates neural progenitor fate during human brain development

Martina Polenghi, Elena Restelli, Andrea Jáñez Pedrayes…·Elena Taverna

This study shows that COG5 deficiency disrupts Golgi organization and affects neural progenitor fate during human brain development through altered trafficking and glycosylation.

DOI 10.64898/2026.10.27.760061

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCellular and Molecular Life SciencesPeer-reviewedMar 21, 2025

Nicotinamide Metabolism Reprogramming Drives Reversible Senescence of Glioblastoma Cells

Ashwin Narayanan, Mirca Saras Saurty-Seerunghen, Jessica Michieletto…·Elias A. El-Habr

This study shows nicotinamide induces reversible senescence in glioblastoma cells by reprogramming metabolism and reducing SOX2, with senescent cells retaining tumor-forming ability.

10 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky